UnitedHealth Group Inc. (UNH) Upgraded to “Buy” at Vetr Inc.
UnitedHealth Group Inc. (NYSE:UNH) was upgraded by analysts at Vetr to a “buy” rating in a report issued on Friday.
Several other brokerages have also recently issued reports on UNH. Oppenheimer Holdings Inc. reaffirmed an “outperform” rating and issued a $161.00 target price (up from $145.00) on shares of UnitedHealth Group in a report on Friday, July 22nd. Barclays PLC boosted their price objective on shares of UnitedHealth Group from $151.00 to $164.00 and gave the company an “overweight” rating in a report on Wednesday, July 20th. Citigroup Inc. boosted their price objective on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a “buy” rating in a report on Wednesday, July 20th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a report on Friday, July 22nd. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $160.00 price objective for the company in a report on Friday, July 22nd. One research analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $155.35.
UnitedHealth Group (NYSE:UNH) traded up 0.14% during mid-day trading on Friday, reaching $136.66. 2,568,703 shares of the company’s stock traded hands. The stock has a 50 day moving average of $137.80 and a 200 day moving average of $136.35. The company has a market cap of $130.15 billion, a P/E ratio of 21.39 and a beta of 0.57. UnitedHealth Group has a 12-month low of $107.51 and a 12-month high of $144.48.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.89 by $0.07. The business earned $46.50 billion during the quarter, compared to analysts’ expectations of $45.05 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. On average, equities research analysts predict that UnitedHealth Group will post $7.90 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a $0.625 dividend. This represents a $2.50 annualized dividend and a dividend yield of 1.83%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
In other news, Director Richard T. Burke sold 40,000 shares of the stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the sale, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.65% of the stock is currently owned by insiders.
Large investors have recently made changes to their positions in the stock. Emerald Acquisition Ltd. purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $309,266,000. Bank of Montreal Can purchased a new stake in shares of UnitedHealth Group during the second quarter valued at $207,013,000. Dodge & Cox increased its stake in shares of UnitedHealth Group by 9.6% in the first quarter. Dodge & Cox now owns 15,183,189 shares of the healthcare conglomerate’s stock valued at $1,957,113,000 after buying an additional 1,324,136 shares in the last quarter. Boston Partners increased its position in UnitedHealth Group by 47.6% in the second quarter. Boston Partners now owns 3,531,669 shares of the healthcare conglomerate’s stock valued at $498,672,000 after buying an additional 1,138,808 shares in the last quarter. Finally, Vanguard Group Inc. increased its position in UnitedHealth Group by 2.0% in the second quarter. Vanguard Group Inc. now owns 57,213,923 shares of the healthcare conglomerate’s stock valued at $8,078,605,000 after buying an additional 1,123,084 shares in the last quarter. 85.78% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.